Adjuvant therapy in R0 resected pancreatic cancer patients with gemcitabine plus erlotinib versus gemcitabine for 24 weeks: a prospective randomized phase III study.

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Marianne Sinn, Torsten Liersch, Klaus Gellert, Helmut MessmannORCiDGND, Wolf O. Bechstein, Dirk Waldschmidt, Lutz Jacobasch, Martin Wilhelm, Bettina M Rau, Robert Grützmann, Arndt Weinmann, Georg Maschmeyer, Uwe Pelzer, Jens Stieler, Jana Kaethe Striefler, B. Michael Ghadimi, Marcus Bahra, Helmut Oettle, Bernd Dörken, Hanno Riess
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/89942
ISSN:0732-183XOPAC
ISSN:1527-7755OPAC
Parent Title (English):Journal of Clinical Oncology
Publisher:American Society of Clinical Oncology (ASCO)
Type:Article
Language:English
Year of first Publication:2015
Release Date:2021/10/12
Tag:Cancer Research; Oncology
Volume:33
Issue:15_suppl
First Page:4007
Last Page:4007
DOI:https://doi.org/10.1200/jco.2015.33.15_suppl.4007
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Gastroenterologie